 |
|
|
| |
Lipidomics of metabolic dysfunction-associated steatotic liver disease post-HCV eradication in PWH
|
| |
| |
CROI 2025 SF March 9-12
Rubén Martín-Escolano1,2, Juan Berenguer2,3, Belén Requena4, Ana Virseda-Berdices1,2, Juan Gonzalez-Garcia5,6, Carolina González-Riano4, Cristina Díez2,3,7, Víctor Hontañon5,6, Teresa Aldámiz-Echevarría2,3,7, Coral Barbas4, Salvador Resino1,2, María Angeles Jiménez-Sousa1,2
|
| |
|
|
|
|
|
